BCG_0349 gene-deleted recombinant bacillus calmette-guerin vaccine as well as construction method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HUAZHONG AGRI UNIV
- Publication Date
- 2021-03-12
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of prevention and treatment of zoonoses, and relates to BCG, in particular to a gene-deleted recombinant BCG, and also relates to a construction method and application of the strain. Background technique
[0002] Bovine tuberculosis is a chronic consumptive zoonotic disease that occurs in a variety of animals and humans, and has brought huge economic losses to the world's cattle industry and public health. Mycobacterium bovis (M.bovis) is the main pathogenic bacterium that causes bovine tuberculosis, and it has 99.95% homology at the gene level with the main pathogenic bacterium of human tuberculosis, Mycobacterium tuberculosis (M.tb) , so the infection spectrum crosses each other, and both can infect almost all vertebrates, including humans. For this reason, the only official vaccine currently used to prevent human tuberculosis is an attenuated strain of Mycobacterium bovis - Mycobacterium bovis Bacille Ca...